Table 1. Patient demographics and faricimab treatment results .
Abbreviations: BCVA: best corrected visual acuity; CST: central subfield thickness; diff: difference; F: female; fu: follow up; IRF: inj: injection; intraretinal fluid; logMAR: Log of Minimum Angle of Resolution; M: male; mths: months; No: number; OD: right eye; OS: left eye; SRF: subretinal fluid;tx: treatment; yrs: years; µm: micrometers
| Case No | Gender/ age(yrs)/ eye | No. of Inj | CST before faricimab tx(µm) | CST 1 mth diff (µm) | CST 3 mths diff (µm) | CST overall diff (µm) | IRF/SRF Height after faricimab tx(µm) | IRF/SRF Height 1 mth diff(µm) | IRF/SRF Height 3 mths diff(µm) | IRF/SRF Height overall diff(µm) | BCVA baseline (logMAR) | BCVA after faricimab tx (logMAR) | BCVA diff (logMAR) | faricimab tx fu (mths) |
| 1 | F/80/OD | 1 | 464 | 0 | -9 | -9 | 422 | -111 | -124 | -155 | 0.544 | 0.544 | 0 | 4.9 |
| 2 | 464 | 311 | ||||||||||||
| 3 | 406 | 304 | ||||||||||||
| 4 | 455 | 298 | ||||||||||||
| 5 | 455 | 267 | ||||||||||||
| 2 | M/89/OD | 1 | 455 | -142 | -208 | -196 | 215 | -171 | -215 | -215 | 0.398 | 0.398 | 0 | 4.8 |
| 2 | 313 | 44 | ||||||||||||
| 3 | 360 | 37 | ||||||||||||
| 4 | 247 | 0 | ||||||||||||
| 5 | 265 | 0 | ||||||||||||
| 6 | 259 | 0 | ||||||||||||
| 3 | F/87/OD | 1 | 346 | -1 | -22 | -31 | 67 | 75 | -67 | -67 | 0.602 | 0.602 | 0 | 3.7 |
| 2 | 345 | 142 | ||||||||||||
| 3 | 323 | 0 | ||||||||||||
| 4 | 324 | 0 | ||||||||||||
| 5 | 315 | 0 | ||||||||||||
| 4 | F/72/OS | 1 | 416 | -56 | -80 | -80 | 111 | -111 | -111 | -111 | 1.301 | 1.301 | 0 | 3.7 |
| 2 | 360 | 0 | ||||||||||||
| 3 | 327 | 0 | ||||||||||||
| 4 | 336 | 0 | ||||||||||||
| 5 | M/84/OD | 1 | 369 | 28 | -48 | -48 | 97 | -1 | -53 | -53 | 0.544 | 0.544 | 0 | 3.7 |
| 2 | 397 | 96 | ||||||||||||
| 3 | 386 | 52 | ||||||||||||
| 4 | 321 | 44 | ||||||||||||
| 6 | M/84/OS | 1 | 306 | -13 | -21 | -21 | 89 | -89 | -89 | -89 | 0.176 | 0.176 | 0 | 2.6 |
| 2 | 293 | 0 | ||||||||||||
| 3 | 285 | 0 | ||||||||||||
| 7 | M/77/OS | 1 | 326 | -41 | -49 | -49 | 252 | -119 | -133 | -133 | 1 | 1 | 0 | 2.8 |
| 2 | 285 | 133 | ||||||||||||
| 3 | 277 | 119 | ||||||||||||
| 8 | F/82/OS | 1 | 342 | -2 | -10 | -10 | 67 | -15 | -30 | -30 | 0.301 | 0.301 | 0 | 2.8 |
| 2 | 340 | 52 | ||||||||||||
| 3 | 337 | 52 | ||||||||||||
| 4 | 332 | 37 | ||||||||||||
| 9 | F/89/OD | 1 | 248 | -5 | -2 | -4 | 682 | -15 | -177 | -238 | 0.301 | 0.301 | 0 | 6.1 |
| 2 | 243 | 667 | ||||||||||||
| 3 | 245 | 563 | ||||||||||||
| 4 | 246 | 505 | ||||||||||||
| 5 | 244 | 444 | ||||||||||||
| 10 | M/87/OD | 1 | 314 | 4 | - | 4 | 74 | -34 | - | -34 | 1.602 | 1.602 | 0 | 1.9 |
| 2 | 318 | 40 | ||||||||||||
| 11 | F/69/OD | 1 | 340 | 2 | 2 | 2 | 89 | -15 | -89 | -89 | 0.0969 | 0.0969 | 0 | 2.8 |
| 2 | 342 | 74 | ||||||||||||
| 3 | 342 | 0 | ||||||||||||
| 12 | F/69/OD | 1 | 315 | -8 | - | -8 | 74 | -13 | - | -13 | 0.301 | 0.301 | 0 | 2.7 |
| 2 | 307 | 61 | ||||||||||||
| 13 | F/84/OD | 1 | 521 | -18 | - | -18 | 259 | 52 | - | 52 | 0.544 | 0.398 | -0.146 | 1.6 |
| 2 | 503 | 311 | ||||||||||||
| median (µm) | -5 | -21.5 | -18 | -15 | -89 | -89 | ||||||||
| Interquartile range (µm) | 1 to 29.5 | 7.25 to 56.8 | 6 to 48.5 | 7 to 111 | 70.5 to 155 | 32 to 144 | ||||||||